NM_001009944.3:c.*844_*845dupTG
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001009944.3(PKD1):c.*844_*845dupTG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.045 ( 274 hom., cov: 0)
Exomes 𝑓: 0.042 ( 209 hom. )
Consequence
PKD1
NM_001009944.3 3_prime_UTR
NM_001009944.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.365
Publications
1 publications found
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 16-2088881-G-GCA is Benign according to our data. Variant chr16-2088881-G-GCA is described in ClinVar as [Likely_benign]. Clinvar id is 1217705.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.*844_*845dupTG | 3_prime_UTR_variant | Exon 46 of 46 | 1 | NM_001009944.3 | ENSP00000262304.4 | |||
TSC2 | ENST00000219476.9 | c.*288_*289dupCA | 3_prime_UTR_variant | Exon 42 of 42 | 5 | NM_000548.5 | ENSP00000219476.3 |
Frequencies
GnomAD3 genomes AF: 0.0452 AC: 6623AN: 146594Hom.: 273 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
6623
AN:
146594
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0421 AC: 11556AN: 274228Hom.: 209 Cov.: 0 AF XY: 0.0415 AC XY: 6019AN XY: 144900 show subpopulations
GnomAD4 exome
AF:
AC:
11556
AN:
274228
Hom.:
Cov.:
0
AF XY:
AC XY:
6019
AN XY:
144900
show subpopulations
African (AFR)
AF:
AC:
148
AN:
7194
American (AMR)
AF:
AC:
1398
AN:
10042
Ashkenazi Jewish (ASJ)
AF:
AC:
180
AN:
8408
East Asian (EAS)
AF:
AC:
2681
AN:
18630
South Asian (SAS)
AF:
AC:
1207
AN:
36154
European-Finnish (FIN)
AF:
AC:
336
AN:
14032
Middle Eastern (MID)
AF:
AC:
61
AN:
1092
European-Non Finnish (NFE)
AF:
AC:
4918
AN:
163214
Other (OTH)
AF:
AC:
627
AN:
15462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
470
941
1411
1882
2352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0452 AC: 6626AN: 146698Hom.: 274 Cov.: 0 AF XY: 0.0464 AC XY: 3328AN XY: 71752 show subpopulations
GnomAD4 genome
AF:
AC:
6626
AN:
146698
Hom.:
Cov.:
0
AF XY:
AC XY:
3328
AN XY:
71752
show subpopulations
African (AFR)
AF:
AC:
794
AN:
37472
American (AMR)
AF:
AC:
1943
AN:
14952
Ashkenazi Jewish (ASJ)
AF:
AC:
94
AN:
3424
East Asian (EAS)
AF:
AC:
713
AN:
5108
South Asian (SAS)
AF:
AC:
224
AN:
4786
European-Finnish (FIN)
AF:
AC:
320
AN:
10348
Middle Eastern (MID)
AF:
AC:
12
AN:
288
European-Non Finnish (NFE)
AF:
AC:
2419
AN:
67370
Other (OTH)
AF:
AC:
105
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
287
574
862
1149
1436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 14, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.